Jeuveau (prabotulinumtoxinA) Disease Interactions
There are 4 disease interactions with Jeuveau (prabotulinumtoxinA):
PrabotulinumtoxinA (applies to Jeuveau) infections
Major Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
The administration of prabotulinumtoxinA is contraindicated in the presence of infection at the proposed injection site(s).
PrabotulinumtoxinA (applies to Jeuveau) cardiovascular toxicity
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Cardiovascular Disease, Heart Disease
The administration of prabotulinumtoxinA may cause cardiovascular adverse events, including arrhythmia and myocardial infarction, some with fatal outcomes. It is recommended to monitor and use caution when using this agent in patients with preexisting cardiovascular disease.
PrabotulinumtoxinA (applies to Jeuveau) dysphagia/breathing
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Pulmonary Impairment
The administration of botulinum toxin products, including prabotulinumtoxinA can result in swallowing or breathing difficulties. Patients with preexisting swallowing or breathing difficulties may be more susceptible to these complications. Patients treated with botulinum toxin products may require immediate medical attention should they develop problems with swallowing, speech or breathing. These reactions can occur within hours to weeks after injection with botulinum toxin. Caution is recommended when using this agent in patients at risk.
PrabotulinumtoxinA (applies to Jeuveau) neuromuscular disorders
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Peripheral Neuropathy, Myasthenia Gravis
The administration of prabotulinumtoxinA to patients with preexisting neuromuscular disorders may increase the risk of clinically significant effects, including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia and respiratory compromise. Exercise care when using this agent in patients at risk.
Jeuveau (prabotulinumtoxinA) drug interactions
There are 112 drug interactions with Jeuveau (prabotulinumtoxinA)
More about Jeuveau (prabotulinumtoxinA)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: skeletal muscle relaxants
- FDA Approval History
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|